LANREOTIDE ACETATE

LANREOTIDE ACETATE was reported 7953 times

LANREOTIDE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD CHROMOGRANIN A 4 0.4444
1 GENITOURINARY TRACT NEOPLASM 11 0.1325
2 REST REGIMEN 6 0.1250
3 INSULIN-LIKE GROWTH FACTOR ABNORMAL 12 0.1062
4 PITUITARY TUMOUR REMOVAL 9 0.0947
5 CARCINOID HEART DISEASE 8 0.0879
6 CARCINOID CRISIS 18 0.0796
7 HEPATIC EMBOLISATION 6 0.0759
8 GROWTH HORMONE DEFICIENCY 30 0.0756
9 STOMATITIS HAEMORRHAGIC 9 0.0738
10 BLOOD GROWTH HORMONE INCREASED 41 0.0735
11 INSULIN-LIKE GROWTH FACTOR INCREASED 101 0.0708
12 SERUM SEROTONIN INCREASED 23 0.0648
13 CYTOREDUCTIVE SURGERY 4 0.0645
14 BLOOD CHROMOGRANIN A INCREASED 27 0.0588
15 METASTASES TO SPINAL CORD 11 0.0567
16 BILIRUBIN URINE PRESENT 6 0.0504
17 CARCINOID TUMOUR PULMONARY 12 0.0498
18 PELVIC NEOPLASM 16 0.0462
19 CARCINOID SYNDROME 15 0.0414
20 BLOOD GROWTH HORMONE ABNORMAL 5 0.0410
21 PRODUCT ADMINISTERED BY WRONG PERSON 13 0.0340
22 INJECTION SITE GRANULOMA 8 0.0338
23 BENIGN PANCREATIC NEOPLASM 6 0.0316
24 GALLBLADDER NEOPLASM 4 0.0315
25 BLOOD GROWTH HORMONE DECREASED 6 0.0297
26 NEUROENDOCRINE CARCINOMA METASTATIC 7 0.0285
27 PRODUCT INEFFECTIVE 22 0.0280
28 LACK OF APPLICATION SITE ROTATION 4 0.0265
29 METASTASES TO ABDOMINAL CAVITY 12 0.0244
30 FAT TISSUE DECREASED 9 0.0231
31 LACK OF ADMINISTRATION SITE ROTATION 7 0.0230
32 PITUITARY TUMOUR BENIGN 36 0.0221
33 HEPATIC NEOPLASM 68 0.0208
34 SALPINGECTOMY 11 0.0192
35 PANCREATIC NEUROENDOCRINE TUMOUR 12 0.0187
36 METASTASES TO HEART 5 0.0166
37 THERAPEUTIC EMBOLISATION 5 0.0160
38 HEPATECTOMY 5 0.0160
39 METASTASES TO THORAX 4 0.0158
40 ACROMEGALY 5 0.0158
41 FAECES PALE 35 0.0157
42 TUMOUR PAIN 20 0.0152
43 TOOTH DEPOSIT 5 0.0144
44 PALLIATIVE CARE 22 0.0144
45 GASTROINTESTINAL MICROORGANISM OVERGROWTH 5 0.0142
46 INJECTION SITE CYST 4 0.0137
47 OOPHORECTOMY 12 0.0134
48 NEUROENDOCRINE TUMOUR 19 0.0134
49 RENAL ARTERY THROMBOSIS 4 0.0129
50 WHITE COAT HYPERTENSION 7 0.0129
51 TREATMENT DELAYED 21 0.0121
52 METASTASES TO BONE MARROW 6 0.0120
53 HYPOAESTHESIA EYE 7 0.0119
54 ABDOMINAL CAVITY DRAINAGE 5 0.0118
55 BRAIN NEOPLASM BENIGN 6 0.0117
56 PSEUDOSTROKE 4 0.0116
57 INSULIN-LIKE GROWTH FACTOR DECREASED 6 0.0113
58 BILIARY OBSTRUCTION 14 0.0108
59 METASTASES TO STOMACH 4 0.0102
60 INJECTION SITE MASS 377 0.0102
61 PITUITARY TUMOUR 15 0.0101
62 TUMOUR EXCISION 8 0.0099
63 LACK OF INJECTION SITE ROTATION 17 0.0097
64 PANCREATIC FAILURE 17 0.0096
65 FAECAL VOMITING 5 0.0094
66 NEUROGENIC SHOCK 5 0.0092
67 MAGNESIUM DEFICIENCY 4 0.0085
68 STEATORRHOEA 22 0.0082
69 SITTING DISABILITY 5 0.0081
70 GASTROINTESTINAL NEOPLASM 7 0.0081
71 CARCINOID TUMOUR 6 0.0081
72 PRODUCT SUPPLY ISSUE 57 0.0080
73 INJECTION SITE NODULE 87 0.0079
74 ABDOMINAL NEOPLASM 7 0.0078
75 THYROID HORMONES DECREASED 6 0.0075
76 SOLAR LENTIGO 7 0.0074
77 SPINAL CORD NEOPLASM 6 0.0069
78 MALIGNANT PERITONEAL NEOPLASM 4 0.0068
79 INJECTION SITE SCAR 19 0.0067
80 VENA CAVA THROMBOSIS 11 0.0066
81 PALATAL DISORDER 4 0.0066
82 OBSTRUCTIVE PANCREATITIS 5 0.0065
83 BONE NEOPLASM 7 0.0065
84 HEPATIC LESION 28 0.0065
85 HEPATIC PAIN 27 0.0063
86 BLOOD PRESSURE MEASUREMENT 4 0.0062
87 FAECES SOFT 45 0.0062
88 PROCEDURAL VOMITING 4 0.0062
89 CORTISOL DECREASED 7 0.0061
90 HAEMANGIOMA OF LIVER 6 0.0060
91 PULMONARY PAIN 17 0.0058
92 ADENOMA BENIGN 5 0.0058
93 INCORRECT DRUG ADMINISTRATION RATE 24 0.0056
94 PYELONEPHRITIS ACUTE 11 0.0056
95 MENOPAUSAL SYMPTOMS 13 0.0056
96 METASTASES TO LIVER 98 0.0056
97 UTERINE PROLAPSE 6 0.0055
98 CHOLANGITIS ACUTE 4 0.0053
99 INJECTION SITE ABSCESS 13 0.0052
100 HYPOPARATHYROIDISM 4 0.0052
101 INJECTION SITE SCAB 5 0.0052
102 BILIARY COLIC 15 0.0052
103 METASTASES TO SPINE 17 0.0051
104 REFLUX GASTRITIS 6 0.0050
105 PROCEDURAL NAUSEA 4 0.0050
106 INJECTION SITE DISCOMFORT 52 0.0049
107 FLATULENCE 279 0.0049
108 SCIATIC NERVE INJURY 4 0.0048
109 TERMINAL STATE 32 0.0048
110 GLUCOSE TOLERANCE IMPAIRED 28 0.0047
111 EYE CONTUSION 10 0.0047
112 INFECTED BITE 4 0.0047
113 BILE DUCT STONE 15 0.0047
114 HORMONE LEVEL ABNORMAL 23 0.0047
115 HEPATIC MASS 9 0.0047
116 ABNORMAL FAECES 38 0.0046
117 NEOPLASM 52 0.0045
118 ABDOMINAL MASS 12 0.0045
119 CHOLECYSTITIS INFECTIVE 12 0.0043
120 CHOLELITHIASIS 137 0.0042
121 BILE DUCT STENOSIS 5 0.0042
122 NEOPLASM PROGRESSION 144 0.0041
123 DEVICE SAFETY FEATURE ISSUE 4 0.0041
124 MASTECTOMY 7 0.0040
125 CORONAVIRUS TEST POSITIVE 4 0.0039
126 DISCOURAGEMENT 9 0.0038
127 THYROID HORMONES INCREASED 4 0.0038
128 PHARYNGEAL PARAESTHESIA 6 0.0038
129 BLOOD GLUCOSE FLUCTUATION 41 0.0037
130 GALLBLADDER ENLARGEMENT 4 0.0037
131 TONGUE DRY 5 0.0037
132 PANCREATIC CYST 7 0.0037
133 RADIOTHERAPY 7 0.0037
134 PANCREATIC DISORDER 18 0.0036
135 MALIGNANT NEOPLASM PROGRESSION 371 0.0036
136 DEFAECATION URGENCY 25 0.0036
137 SPLEEN DISORDER 6 0.0035
138 BOWEL MOVEMENT IRREGULARITY 27 0.0035
139 BRONCHIOLITIS 12 0.0034
140 VITAMIN D DECREASED 29 0.0034
141 COMPLEX REGIONAL PAIN SYNDROME 5 0.0034
142 INDURATION 6 0.0034
143 INTRA-ABDOMINAL FLUID COLLECTION 6 0.0033
144 ABDOMINAL RIGIDITY 9 0.0033
145 THYROID NEOPLASM 9 0.0033
146 FAECES DISCOLOURED 69 0.0032
147 HEPATOMEGALY 31 0.0032
148 TONGUE BLISTERING 7 0.0031
149 GASTROINTESTINAL HYPOMOTILITY 7 0.0031
150 GASTROINTESTINAL PAIN 34 0.0031
151 BLOOD GLUCOSE ABNORMAL 57 0.0031
152 LIP INJURY 4 0.0031
153 BLOOD PRESSURE DIASTOLIC INCREASED 14 0.0030
154 GASTROINTESTINAL SOUNDS ABNORMAL 15 0.0030
155 RHINALGIA 8 0.0029
156 HEART RATE DECREASED 101 0.0029
157 PRODUCT EXPIRATION DATE ISSUE 4 0.0029
158 VERTIGO POSITIONAL 5 0.0029
159 BLOOD ELECTROLYTES DECREASED 4 0.0028
160 METASTASES TO LYMPH NODES 19 0.0028
161 PROSTATOMEGALY 11 0.0028
162 INJECTION SITE HYPOAESTHESIA 4 0.0028
163 BLADDER SPASM 5 0.0027
164 NEEDLE ISSUE 77 0.0026
165 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 45 0.0026
166 ABDOMINAL DISTENSION 273 0.0026
167 BLOOD IRON DECREASED 31 0.0026
168 FAECES HARD 10 0.0026
169 PRODUCT DEPOSIT 4 0.0026
170 TEARFULNESS 11 0.0026
171 RED BLOOD CELL COUNT INCREASED 7 0.0025
172 CHAPPED LIPS 11 0.0025
173 NODULE 33 0.0025
174 METASTASIS 18 0.0025
175 MASS 35 0.0025
176 WEIGHT ABNORMAL 6 0.0025
177 METASTASES TO BONE 41 0.0025
178 GLYCOSYLATED HAEMOGLOBIN DECREASED 4 0.0025
179 FREQUENT BOWEL MOVEMENTS 67 0.0025
180 LIVER ABSCESS 8 0.0025
181 ABDOMINAL PAIN 573 0.0025
182 HAEMATOLOGICAL INFECTION 6 0.0025
183 VITAMIN B12 DECREASED 7 0.0024
184 GASTROINTESTINAL MOTILITY DISORDER 13 0.0024
185 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
186 RENAL PAIN 25 0.0024
187 RENAL NEOPLASM 5 0.0024
188 HEPATIC CYST 8 0.0024
189 EXPOSURE TO SARS-COV-2 4 0.0024
190 CANCER PAIN 6 0.0023
191 URINE ANALYSIS ABNORMAL 7 0.0023
192 SYMPTOM RECURRENCE 14 0.0023
193 METASTASES TO LUNG 27 0.0023
194 BRAIN NEOPLASM 21 0.0023
195 RESPIRATORY RATE INCREASED 20 0.0023
196 DIARRHOEA 1440 0.0022
197 BLOOD MAGNESIUM DECREASED 19 0.0022
198 PERIARTHRITIS 5 0.0022
199 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 40 0.0022
200 PANCREATITIS NECROTISING 5 0.0022
201 FLUSHING 219 0.0022
202 INTESTINAL OBSTRUCTION 81 0.0021
203 HOSPICE CARE 21 0.0021
204 NEAR DEATH EXPERIENCE 7 0.0021
205 CORONAVIRUS INFECTION 14 0.0021
206 HEART VALVE INCOMPETENCE 6 0.0021
207 DIABETES INSIPIDUS 5 0.0021
208 PULSE ABNORMAL 5 0.0021
209 NEOPLASM RECURRENCE 7 0.0021
210 BLOOD GLUCOSE DECREASED 99 0.0021
211 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
212 HYPOGLYCAEMIA 99 0.0020
213 GALLBLADDER DISORDER 36 0.0020
214 INFREQUENT BOWEL MOVEMENTS 5 0.0020
215 METASTASES TO PERITONEUM 5 0.0020
216 INJECTION SITE NECROSIS 4 0.0020
217 INJECTION SITE PAIN 601 0.0020
218 RENAL MASS 4 0.0019
219 THYROID FUNCTION TEST ABNORMAL 8 0.0019
220 MALABSORPTION 10 0.0019
221 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 135 0.0019
222 EMOTIONAL DISORDER 58 0.0019
223 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
224 MUSCULOSKELETAL CHEST PAIN 29 0.0019
225 ASCITES 55 0.0019
226 EXOPHTHALMOS 4 0.0019
227 INJECTION SITE INDURATION 24 0.0018
228 GROIN PAIN 16 0.0018
229 MUCOUS STOOLS 9 0.0018
230 MIDDLE EAR EFFUSION 4 0.0018
231 PRODUCT LOT NUMBER ISSUE 4 0.0018
232 SKIN MASS 12 0.0018
233 SPINAL COLUMN INJURY 4 0.0018
234 SPUTUM DISCOLOURED 17 0.0018
235 DIABETIC COMA 5 0.0018
236 BLOOD CALCIUM DECREASED 20 0.0018
237 BLOOD CHOLESTEROL ABNORMAL 8 0.0017
238 OFF LABEL USE 1514 0.0017
239 PATELLA FRACTURE 4 0.0017
240 ABDOMINAL PAIN LOWER 43 0.0017
241 JAUNDICE CHOLESTATIC 6 0.0017
242 TOXIC SKIN ERUPTION 17 0.0017
243 INTERCEPTED PRODUCT STORAGE ERROR 6 0.0017
244 NEPHROLITHIASIS 77 0.0017
245 CHOLECYSTECTOMY 19 0.0017
246 ERUCTATION 32 0.0017
247 DIZZINESS POSTURAL 16 0.0016
248 BLOOD SODIUM DECREASED 31 0.0016
249 DIABETES MELLITUS INADEQUATE CONTROL 29 0.0016
250 DYSCHEZIA 5 0.0016
251 ASTHENOPIA 9 0.0016
252 PRODUCT PHYSICAL CONSISTENCY ISSUE 9 0.0016
253 PRODUCT LEAKAGE 9 0.0016
254 FLANK PAIN 15 0.0016
255 BLOOD POTASSIUM DECREASED 48 0.0016
256 BLOOD CALCIUM INCREASED 14 0.0016
257 COLD SWEAT 28 0.0016
258 URINARY TRACT INFECTION BACTERIAL 4 0.0016
259 LABYRINTHITIS 4 0.0016
260 ABDOMINAL DISCOMFORT 265 0.0016
261 CARDIAC VALVE DISEASE 9 0.0016
262 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
263 LIPOMA 4 0.0015
264 ABDOMINAL PAIN UPPER 317 0.0015
265 URINE OUTPUT INCREASED 4 0.0015
266 PERSONALITY DISORDER 4 0.0015
267 BODY TEMPERATURE DECREASED 15 0.0015
268 LOCALISED OEDEMA 7 0.0015
269 CHOLECYSTITIS 18 0.0015
270 HAEMORRHOIDS 29 0.0015
271 DEATH 1278 0.0015
272 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 71 0.0015
273 WEIGHT DECREASED 409 0.0015
274 REGURGITATION 5 0.0015
275 THIRST 26 0.0015
276 MUSCULOSKELETAL DISCOMFORT 25 0.0015
277 CHOLANGITIS 9 0.0015
278 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
279 TRICHORRHEXIS 4 0.0014
280 BLOOD TEST ABNORMAL 20 0.0014
281 CEREBRAL THROMBOSIS 4 0.0014
282 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 254 0.0014
283 EATING DISORDER 30 0.0014
284 BLOOD PRESSURE ABNORMAL 28 0.0014
285 ABSCESS LIMB 6 0.0014
286 TUMOUR HAEMORRHAGE 4 0.0014
287 HYPERGLYCAEMIA 51 0.0014
288 HOSPITALISATION 214 0.0014
289 CONSTIPATION 303 0.0014
290 RENAL CYST 11 0.0014
291 DYSPNOEA AT REST 4 0.0014
292 ESCHERICHIA SEPSIS 4 0.0014
293 BONE CANCER 6 0.0014
294 LIVER DISORDER 61 0.0014
295 HAEMATOTOXICITY 13 0.0014
296 FOOD INTOLERANCE 5 0.0014
297 INJECTION SITE HAEMORRHAGE 109 0.0014
298 PRODUCT TEMPERATURE EXCURSION ISSUE 7 0.0014
299 CACHEXIA 7 0.0014
300 GINGIVAL SWELLING 6 0.0014
301 TEMPERATURE INTOLERANCE 14 0.0014
302 DENTAL CARIES 15 0.0014
303 PSYCHIATRIC SYMPTOM 10 0.0014
304 AFFECT LABILITY 13 0.0013
305 DISEASE PROGRESSION 159 0.0013
306 MALNUTRITION 15 0.0013
307 METABOLIC ENCEPHALOPATHY 4 0.0013
308 FULL BLOOD COUNT ABNORMAL 14 0.0013
309 BLOOD THYROID STIMULATING HORMONE DECREASED 6 0.0013
310 PRODUCT DOSE OMISSION ISSUE 388 0.0013
311 FACE INJURY 5 0.0013
312 ANORECTAL DISCOMFORT 7 0.0013
313 BLOOD TESTOSTERONE DECREASED 9 0.0013
314 HOT FLUSH 99 0.0013
315 ONYCHOCLASIS 9 0.0013
316 THYROID MASS 5 0.0013
317 SMALL INTESTINAL OBSTRUCTION 16 0.0013
318 FEEDING DISORDER 26 0.0013
319 EPIGASTRIC DISCOMFORT 5 0.0013
320 BODY TEMPERATURE INCREASED 26 0.0013
321 SWELLING OF EYELID 8 0.0013
322 FATIGUE 983 0.0013
323 SCIATICA 20 0.0013
324 HEART RATE IRREGULAR 28 0.0012
325 PORTAL VEIN THROMBOSIS 4 0.0012
326 CHOLECYSTITIS ACUTE 7 0.0012
327 HEPATIC STEATOSIS 23 0.0012
328 LIQUID PRODUCT PHYSICAL ISSUE 9 0.0012
329 PRESYNCOPE 30 0.0012
330 THYROID DISORDER 19 0.0012
331 DEPRESSED MOOD 65 0.0012
332 DECUBITUS ULCER 10 0.0012
333 BRADYCARDIA 65 0.0012
334 ANAL INCONTINENCE 11 0.0012
335 GOITRE 5 0.0012
336 INJECTION SITE INFECTION 4 0.0012
337 SARS-COV-2 TEST POSITIVE 16 0.0012
338 BLOOD GLUCOSE INCREASED 228 0.0012
339 DECREASED APPETITE 280 0.0012
340 METABOLIC DISORDER 7 0.0012
341 INJECTION SITE INFLAMMATION 6 0.0012
342 SKIN LACERATION 13 0.0012
343 INJECTION SITE PRURITUS 80 0.0012
344 NERVE COMPRESSION 11 0.0012
345 GASTROINTESTINAL DISORDER 106 0.0012
346 TASTE DISORDER 24 0.0012
347 TONGUE DISCOMFORT 5 0.0012
348 PERIPHERAL COLDNESS 16 0.0012
349 MUSCLE STRAIN 10 0.0012
350 ALOPECIA 226 0.0011
351 BEDRIDDEN 15 0.0011
352 ATELECTASIS 11 0.0011
353 BLOOD PRESSURE INCREASED 174 0.0011
354 HYPOTHYROIDISM 36 0.0011
355 BLOOD DISORDER 9 0.0011
356 GASTROINTESTINAL INFECTION 10 0.0011
357 ASTHENIA 418 0.0011
358 SUSPECTED OFF LABEL USE 5 0.0011
359 BLOOD URINE PRESENT 21 0.0011
360 HYPERTENSION 234 0.0011
361 SLEEP APNOEA SYNDROME 21 0.0011
362 POLYURIA 9 0.0011
363 INCREASED APPETITE 21 0.0011
364 FAECALOMA 6 0.0011
365 UTERINE LEIOMYOMA 8 0.0011
366 POST PROCEDURAL COMPLICATION 21 0.0011
367 ILLNESS 112 0.0011
368 LABORATORY TEST ABNORMAL 32 0.0011
369 PRODUCT USE COMPLAINT 17 0.0011
370 FEELING COLD 30 0.0011
371 HEART RATE ABNORMAL 6 0.0011
372 YELLOW SKIN 5 0.0011
373 CHEMOTHERAPY 4 0.0011
374 TUMOUR MARKER INCREASED 5 0.0010
375 BLOOD PRESSURE FLUCTUATION 25 0.0010
376 PRODUCT ADMINISTRATION ERROR 21 0.0010
377 DIABETES MELLITUS 79 0.0010
378 CONCUSSION 8 0.0010
379 FINGER DEFORMITY 5 0.0010
380 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
381 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
382 NAIL DISCOLOURATION 4 0.0010
383 MALAISE 446 0.0010
384 HYPERVOLAEMIA 5 0.0010
385 EXTRASYSTOLES 7 0.0010
386 FUNGAL SKIN INFECTION 4 0.0010
387 FRUSTRATION TOLERANCE DECREASED 8 0.0010
388 RECURRENT CANCER 4 0.0010
389 CONTUSION 94 0.0010
390 SELF-MEDICATION 4 0.0010
391 SYNCOPE 97 0.0010
392 DISCOMFORT 59 0.0010
393 HYPOKINESIA 14 0.0010
394 HEAD DISCOMFORT 17 0.0010
395 TENDERNESS 10 0.0010
396 LIMB INJURY 26 0.0010
397 IMPAIRED GASTRIC EMPTYING 13 0.0010
398 SPINAL DISORDER 9 0.0009
399 SENSITIVE SKIN 7 0.0009
400 DEVICE MECHANICAL ISSUE 13 0.0009
401 MUSCLE ATROPHY 12 0.0009
402 HYPERSOMNIA 27 0.0009
403 AORTIC VALVE INCOMPETENCE 4 0.0009
404 HEART RATE INCREASED 93 0.0009
405 LETHARGY 54 0.0009
406 BACK PAIN 218 0.0009
407 DEHYDRATION 125 0.0009
408 LUNG NEOPLASM 4 0.0009
409 NAUSEA 735 0.0009
410 METASTATIC NEOPLASM 4 0.0009
411 HORDEOLUM 4 0.0009
412 NERVOUSNESS 48 0.0009
413 PALLOR 25 0.0009
414 HEAD INJURY 29 0.0009
415 DIVERTICULUM INTESTINAL 4 0.0009
416 SYRINGE ISSUE 16 0.0009
417 NOCTURIA 11 0.0009
418 APPETITE DISORDER 6 0.0009
419 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
420 INJECTION SITE INJURY 5 0.0009
421 NERVE INJURY 10 0.0009
422 PELVIC FRACTURE 7 0.0009
423 THERAPY PARTIAL RESPONDER 14 0.0009
424 BREAST MASS 6 0.0009
425 IRON DEFICIENCY 4 0.0009
426 PERIPHERAL SWELLING 137 0.0009
427 PNEUMOTHORAX 14 0.0009
428 SLUGGISHNESS 9 0.0009
429 TRICUSPID VALVE INCOMPETENCE 7 0.0009
430 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
431 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
432 HAEMOGLOBIN INCREASED 4 0.0009
433 LOSS OF CONSCIOUSNESS 112 0.0009
434 DYSPEPSIA 86 0.0009
435 IMMUNE THROMBOCYTOPENIA 4 0.0009
436 POLLAKIURIA 36 0.0009
437 RALES 5 0.0009
438 DYSPNOEA EXERTIONAL 32 0.0008
439 BLOOD PROLACTIN INCREASED 4 0.0008
440 DECREASED INTEREST 5 0.0008
441 LYMPHADENOPATHY 30 0.0008
442 ENERGY INCREASED 5 0.0008
443 SKIN ABRASION 4 0.0008
444 DIZZINESS 422 0.0008
445 GASTRIC ULCER 16 0.0008
446 INCORRECT ROUTE OF DRUG ADMINISTRATION 30 0.0008
447 OEDEMA PERIPHERAL 102 0.0008
448 SURGERY 49 0.0008
449 CHOLESTASIS 16 0.0008
450 TYPE 2 DIABETES MELLITUS 28 0.0008
451 GENERAL PHYSICAL HEALTH DETERIORATION 96 0.0008
452 WOUND 23 0.0008
453 QUALITY OF LIFE DECREASED 11 0.0008
454 INJECTION SITE EXTRAVASATION 10 0.0008
455 HEADACHE 507 0.0008
456 PYELONEPHRITIS 7 0.0008
457 HYPERHIDROSIS 104 0.0008
458 CYST 10 0.0008
459 ANEURYSM 4 0.0008
460 INJECTION SITE DISCOLOURATION 10 0.0008
461 FLUID INTAKE REDUCED 4 0.0008
462 PANCREATITIS 42 0.0008
463 OEDEMA 43 0.0008
464 PHOTOPSIA 5 0.0008
465 VOMITING 371 0.0008
466 MICTURITION URGENCY 9 0.0008
467 DRY THROAT 8 0.0008
468 AMMONIA INCREASED 4 0.0008
469 BLOOD PRESSURE DECREASED 52 0.0008
470 NIGHT SWEATS 25 0.0008
471 GASTROENTERITIS VIRAL 14 0.0008
472 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
473 MOOD ALTERED 21 0.0008
474 PETECHIAE 8 0.0008
475 BRAIN FOG 12 0.0008
476 DRUG ADMINISTERED AT INAPPROPRIATE SITE 8 0.0008
477 INCONTINENCE 8 0.0008
478 HYPOTENSION 151 0.0008
479 RENAL DISORDER 35 0.0008
480 WRIST FRACTURE 9 0.0008
481 HAEMATEMESIS 19 0.0007
482 FOOD POISONING 4 0.0007
483 PRODUCT AVAILABILITY ISSUE 17 0.0007
484 MUSCLE SPASMS 137 0.0007
485 IRRITABLE BOWEL SYNDROME 16 0.0007
486 ANAL FISSURE 4 0.0007
487 INTESTINAL RESECTION 4 0.0007
488 SINUS CONGESTION 10 0.0007
489 HIP SURGERY 4 0.0007
490 COVID-19 129 0.0007
491 DYSPHONIA 43 0.0007
492 BONE PAIN 43 0.0007
493 ABNORMAL LOSS OF WEIGHT 5 0.0007
494 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
495 RIB FRACTURE 15 0.0007
496 TOOTH FRACTURE 8 0.0007
497 MUSCULOSKELETAL PAIN 38 0.0007
498 PLEURAL EFFUSION 44 0.0007
499 LIVER FUNCTION TEST ABNORMAL 21 0.0007
500 DIVERTICULITIS 20 0.0007
501 PRODUCT DOSE OMISSION 47 0.0007
502 TOOTHACHE 13 0.0007
503 ORAL PAIN 16 0.0007
504 CARPAL TUNNEL SYNDROME 10 0.0007
505 SENSATION OF FOREIGN BODY 6 0.0007
506 LIGAMENT SPRAIN 7 0.0007
507 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12 0.0007
508 ADVERSE EVENT 65 0.0007
509 DIVERTICULUM 5 0.0007
510 DRY MOUTH 57 0.0007
511 SPINAL FRACTURE 14 0.0007
512 CARDIAC OPERATION 6 0.0007
513 HERPES VIRUS INFECTION 4 0.0007
514 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
515 HYSTERECTOMY 6 0.0007
516 URINARY TRACT INFECTION 118 0.0007
517 ELECTROLYTE IMBALANCE 8 0.0007
518 NAIL DISORDER 6 0.0007
519 APATHY 10 0.0007
520 FEELING HOT 42 0.0007
521 WEIGHT INCREASED 153 0.0007
522 MYALGIA 116 0.0007
523 AGEUSIA 17 0.0007
524 CHEST PAIN 126 0.0007
525 DEMENTIA 19 0.0007
526 CEREBRAL DISORDER 5 0.0007
527 CARDIAC DISORDER 63 0.0007
528 HERNIA 13 0.0007
529 HYPOKALAEMIA 31 0.0007
530 GENERAL SYMPTOM 5 0.0007
531 ARTHRALGIA 277 0.0007
532 HYPOPHAGIA 17 0.0007
533 PAROSMIA 5 0.0007
534 FALL 220 0.0007
535 NEOPLASM MALIGNANT 44 0.0007
536 BONE DISORDER 12 0.0007
537 BLOOD UREA INCREASED 11 0.0007
538 TENSION 4 0.0007
539 CATARACT 39 0.0007
540 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
541 DRUG ABUSER 4 0.0007
542 DYSSTASIA 19 0.0007
543 MENISCUS INJURY 4 0.0006
544 PAIN 399 0.0006
545 CHILLS 76 0.0006
546 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
547 ATRIOVENTRICULAR BLOCK 5 0.0006
548 INCORRECT PRODUCT ADMINISTRATION DURATION 14 0.0006
549 PRODUCT PRESCRIBING ISSUE 14 0.0006
550 DEVICE OCCLUSION 9 0.0006
551 GASTROINTESTINAL INFLAMMATION 5 0.0006
552 LOWER RESPIRATORY TRACT INFECTION 29 0.0006
553 CYANOSIS 10 0.0006
554 SEASONAL ALLERGY 9 0.0006
555 ARRHYTHMIA 30 0.0006
556 PRODUCT PACKAGING ISSUE 6 0.0006
557 RED BLOOD CELL COUNT DECREASED 18 0.0006
558 HYPERTENSIVE CRISIS 7 0.0006
559 HEPATIC CANCER 15 0.0006
560 SLEEP DISORDER 44 0.0006
561 ANGER 21 0.0006
562 EYE INFECTION 7 0.0006
563 FEELING ABNORMAL 148 0.0006
564 HEPATIC ENZYME INCREASED 42 0.0006
565 HAEMATOCHEZIA 34 0.0006
566 BLOOD POTASSIUM INCREASED 10 0.0006
567 GOUT 11 0.0006
568 PROCEDURAL PAIN 17 0.0006
569 GASTRITIS 16 0.0006
570 UNEVALUABLE EVENT 46 0.0006
571 DYSGRAPHIA 4 0.0006
572 VERTIGO 37 0.0006
573 PULMONARY MASS 9 0.0006
574 UPPER LIMB FRACTURE 12 0.0006
575 MOOD SWINGS 19 0.0006
576 BLOOD BILIRUBIN INCREASED 16 0.0006
577 PAIN IN EXTREMITY 174 0.0006
578 EYE MOVEMENT DISORDER 4 0.0006
579 ANKLE FRACTURE 9 0.0006
580 MYOPATHY 5 0.0006
581 HAIR GROWTH ABNORMAL 4 0.0006
582 LARGE INTESTINE POLYP 4 0.0006
583 BURSITIS 7 0.0006
584 ADRENAL INSUFFICIENCY 7 0.0006
585 ANXIETY 163 0.0006
586 TRANSFUSION 6 0.0006
587 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
588 CARDIOMEGALY 7 0.0006
589 SKIN DISCOLOURATION 26 0.0006
590 PRODUCTIVE COUGH 27 0.0006
591 CYSTITIS 18 0.0006
592 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
593 ORAL HERPES 11 0.0006
594 FEAR OF INJECTION 4 0.0006
595 RECTAL HAEMORRHAGE 24 0.0006
596 ANGINA PECTORIS 16 0.0006
597 ADVERSE DRUG REACTION 50 0.0006
598 HAEMOGLOBIN DECREASED 57 0.0006
599 PANCREATIC CARCINOMA 16 0.0006
600 HYPERTHYROIDISM 8 0.0006
601 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
602 GASTROENTERITIS 8 0.0005
603 GASTROOESOPHAGEAL REFLUX DISEASE 44 0.0005
604 IRON DEFICIENCY ANAEMIA 5 0.0005
605 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
606 PRODUCT DISTRIBUTION ISSUE 5 0.0005
607 PALPITATIONS 63 0.0005
608 SUNBURN 4 0.0005
609 BLOOD CHOLESTEROL INCREASED 25 0.0005
610 INJECTION SITE SWELLING 41 0.0005
611 SKIN INFECTION 6 0.0005
612 INJECTION SITE WARMTH 11 0.0005
613 INFLUENZA LIKE ILLNESS 44 0.0005
614 OXYGEN SATURATION DECREASED 30 0.0005
615 CIRCULATORY COLLAPSE 9 0.0005
616 HYPOCALCAEMIA 10 0.0005
617 TENDON PAIN 4 0.0005
618 SCAR 9 0.0005
619 INTERNAL HAEMORRHAGE 6 0.0005
620 GAIT DISTURBANCE 100 0.0005
621 BLOOD CREATININE INCREASED 34 0.0005
622 JAUNDICE 14 0.0005
623 OROPHARYNGEAL PAIN 48 0.0005
624 PRESCRIBED OVERDOSE 10 0.0005
625 APHTHOUS ULCER 4 0.0005
626 VITAMIN D DEFICIENCY 5 0.0005
627 LIVER FUNCTION TEST INCREASED 11 0.0005
628 SPINAL PAIN 6 0.0005
629 MUSCULAR WEAKNESS 58 0.0005
630 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
631 KIDNEY INFECTION 10 0.0005
632 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
633 AFFECTIVE DISORDER 4 0.0005
634 TACHYCARDIA 45 0.0005
635 HAEMATOCRIT DECREASED 10 0.0005
636 ACCIDENT 6 0.0005
637 INFLUENZA 56 0.0005
638 ABSCESS 8 0.0005
639 NECK PAIN 28 0.0005
640 TINNITUS 23 0.0005
641 OVARIAN CYST 5 0.0005
642 THYROID CANCER 6 0.0005
643 RHINITIS 4 0.0005
644 ARTHRITIS 39 0.0005
645 OSTEOARTHRITIS 21 0.0005
646 MUSCLE TIGHTNESS 8 0.0005
647 FIBROMYALGIA 12 0.0005
648 POST PROCEDURAL INFECTION 4 0.0005
649 FLUID RETENTION 25 0.0005
650 ESCHERICHIA INFECTION 4 0.0005
651 HYPERCALCAEMIA 6 0.0005
652 DRUG DOSE OMISSION BY DEVICE 38 0.0005
653 INSOMNIA 129 0.0005
654 MYELODYSPLASTIC SYNDROME 7 0.0005
655 NASOPHARYNGITIS 89 0.0005
656 TOOTH EXTRACTION 6 0.0005
657 EMBOLISM 4 0.0005
658 VIRAL INFECTION 16 0.0005
659 SECRETION DISCHARGE 6 0.0005
660 GAIT INABILITY 16 0.0005
661 STOMATITIS 29 0.0005
662 FOOT FRACTURE 9 0.0005
663 INJECTION SITE IRRITATION 6 0.0005
664 MIGRAINE 45 0.0005
665 HEPATIC CYTOLYSIS 6 0.0005
666 DEPRESSION 107 0.0005
667 BREAST PAIN 5 0.0005
668 JOINT INJURY 10 0.0005
669 BODY HEIGHT DECREASED 5 0.0005
670 ROTATOR CUFF SYNDROME 6 0.0005
671 PRODUCT CONTAINER ISSUE 4 0.0005
672 POOR QUALITY SLEEP 10 0.0005
673 INJECTION SITE BRUISING 37 0.0005
674 BACK INJURY 5 0.0005
675 URINE OUTPUT DECREASED 4 0.0005
676 INCORRECT PRODUCT STORAGE 6 0.0005
677 WOUND INFECTION 5 0.0005
678 ORAL CANDIDIASIS 6 0.0005
679 WHEEZING 27 0.0005
680 IMMUNE SYSTEM DISORDER 6 0.0005
681 TOOTH INFECTION 6 0.0005
682 DEVICE RELATED INFECTION 7 0.0005
683 TENDONITIS 7 0.0005
684 FOOT DEFORMITY 5 0.0005
685 DYSPNOEA 255 0.0005
686 TOOTH DISORDER 10 0.0004
687 LIVER INJURY 11 0.0004
688 PANCREATITIS ACUTE 10 0.0004
689 HEAVY MENSTRUAL BLEEDING 4 0.0004
690 OROPHARYNGEAL DISCOMFORT 4 0.0004
691 NASAL CONGESTION 26 0.0004
692 BALANCE DISORDER 38 0.0004
693 GINGIVAL BLEEDING 6 0.0004
694 PYREXIA 152 0.0004
695 SCAB 5 0.0004
696 EXOSTOSIS 4 0.0004
697 OSTEOPOROSIS 18 0.0004
698 CARDIAC FAILURE 35 0.0004
699 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
700 COUGH 122 0.0004
701 DYSURIA 16 0.0004
702 HYPOAESTHESIA 65 0.0004
703 OVARIAN CANCER 4 0.0004
704 HEPATIC FAILURE 13 0.0004
705 JOINT SWELLING 52 0.0004
706 LACRIMATION INCREASED 13 0.0004
707 COORDINATION ABNORMAL 6 0.0004
708 APHONIA 6 0.0004
709 POST PROCEDURAL HAEMORRHAGE 5 0.0004
710 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
711 BACTERIAL INFECTION 8 0.0004
712 RENAL IMPAIRMENT 36 0.0004
713 DISTURBANCE IN ATTENTION 23 0.0004
714 LYMPHOPENIA 6 0.0004
715 THROMBOSIS 34 0.0004
716 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
717 MOBILITY DECREASED 30 0.0004
718 AMNESIA 27 0.0004
719 CANDIDA INFECTION 7 0.0004
720 CONDITION AGGRAVATED 126 0.0004
721 EAR INFECTION 11 0.0004
722 CRYING 15 0.0004
723 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
724 DRUG EFFECT DECREASED 22 0.0004
725 INFECTION 59 0.0004
726 SWELLING 38 0.0004
727 HIP FRACTURE 13 0.0004
728 GENERALISED OEDEMA 5 0.0004
729 ANAEMIA 77 0.0004
730 ORTHOSTATIC HYPOTENSION 7 0.0004
731 DEVICE DELIVERY SYSTEM ISSUE 11 0.0004
732 CHEST DISCOMFORT 41 0.0004
733 IRRITABILITY 24 0.0004
734 HYPOXIA 14 0.0004
735 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 80 0.0004
736 HAEMOPTYSIS 11 0.0004
737 VISION BLURRED 54 0.0004
738 TOOTH ABSCESS 4 0.0004
739 URINARY RETENTION 13 0.0004
740 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
741 UNRESPONSIVE TO STIMULI 10 0.0004
742 MEMORY IMPAIRMENT 53 0.0004
743 TREMOR 64 0.0004
744 PELVIC PAIN 7 0.0004
745 RESTLESS LEGS SYNDROME 7 0.0004
746 SWOLLEN TONGUE 12 0.0004
747 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
748 JOINT STIFFNESS 10 0.0004
749 MOUTH ULCERATION 8 0.0004
750 ABNORMAL BEHAVIOUR 15 0.0004
751 CONFUSIONAL STATE 61 0.0004
752 SEPSIS 42 0.0004
753 EYE SWELLING 14 0.0004
754 EYE HAEMORRHAGE 5 0.0004
755 SENSORY DISTURBANCE 6 0.0004
756 RHINORRHOEA 24 0.0004
757 URINARY INCONTINENCE 11 0.0004
758 VISUAL IMPAIRMENT 46 0.0004
759 HYPERKALAEMIA 13 0.0004
760 FRACTURE 7 0.0004
761 BIPOLAR DISORDER 4 0.0004
762 SOMNOLENCE 74 0.0004
763 PNEUMONITIS 10 0.0004
764 DRY SKIN 49 0.0004
765 INTENTIONAL PRODUCT MISUSE 32 0.0004
766 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
767 EAR PAIN 7 0.0004
768 HYPOMAGNESAEMIA 5 0.0004
769 HUNGER 5 0.0004
770 CELLULITIS 18 0.0004
771 PLATELET COUNT DECREASED 38 0.0004
772 PRESCRIBED UNDERDOSE 7 0.0004
773 INFLAMMATION 18 0.0003
774 IMPAIRED QUALITY OF LIFE 5 0.0003
775 DEVICE DEFECTIVE 6 0.0003
776 MENTAL DISORDER 15 0.0003
777 PRODUCT PREPARATION ERROR 7 0.0003
778 THROMBOCYTOPENIA 38 0.0003
779 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
780 CARDIOMYOPATHY 5 0.0003
781 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
782 BACTERAEMIA 4 0.0003
783 NEUROPATHY PERIPHERAL 32 0.0003
784 DISEASE RECURRENCE 16 0.0003
785 COLON CANCER 5 0.0003
786 DEVICE ISSUE 30 0.0003
787 RASH PRURITIC 18 0.0003
788 PRODUCT STORAGE ERROR 29 0.0003
789 APHASIA 10 0.0003
790 SKIN DISORDER 11 0.0003
791 NEURALGIA 8 0.0003
792 RETCHING 7 0.0003
793 INSURANCE ISSUE 5 0.0003
794 SKIN CANCER 7 0.0003
795 BRONCHITIS 24 0.0003
796 LIMB DISCOMFORT 10 0.0003
797 SINUSITIS 33 0.0003
798 ILEUS 4 0.0003
799 EPISTAXIS 24 0.0003
800 BASAL CELL CARCINOMA 5 0.0003
801 MENINGIOMA 5 0.0003
802 INJECTION SITE REACTION 22 0.0003
803 MUSCULOSKELETAL STIFFNESS 28 0.0003
804 PAIN IN JAW 9 0.0003
805 FEELING JITTERY 6 0.0003
806 GLOSSODYNIA 7 0.0003
807 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
808 SKIN ULCER 8 0.0003
809 HIATUS HERNIA 4 0.0003
810 HAEMATOMA 8 0.0003
811 DEAFNESS 8 0.0003
812 DYSPHAGIA 29 0.0003
813 IMPAIRED HEALING 10 0.0003
814 SINUS DISORDER 6 0.0003
815 PERICARDIAL EFFUSION 7 0.0003
816 RESPIRATORY DISORDER 9 0.0003
817 ILL-DEFINED DISORDER 18 0.0003
818 OCULAR HYPERAEMIA 14 0.0003
819 INJECTION SITE RASH 9 0.0003
820 DRUG ADMINISTRATION ERROR 9 0.0003
821 TREATMENT NONCOMPLIANCE 16 0.0003
822 ERYTHEMA 60 0.0003
823 LOCALISED INFECTION 7 0.0003
824 INJECTION SITE URTICARIA 7 0.0003
825 BURNING SENSATION 20 0.0003
826 SKIN REACTION 4 0.0003
827 DRUG ERUPTION 5 0.0003
828 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
829 THERAPY INTERRUPTED 20 0.0003
830 HYPOACUSIS 12 0.0003
831 PARAESTHESIA ORAL 4 0.0003
832 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
833 ANOSMIA 4 0.0003
834 INJECTION SITE HAEMATOMA 4 0.0003
835 EXPIRED PRODUCT ADMINISTERED 9 0.0003
836 ARTHROPATHY 15 0.0003
837 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
838 HEPATIC CIRRHOSIS 5 0.0003
839 INJECTION SITE ERYTHEMA 33 0.0003
840 PRURITUS 102 0.0003
841 OSTEOPENIA 4 0.0003
842 HAEMATURIA 9 0.0003
843 GASTRIC DISORDER 9 0.0003
844 SWELLING FACE 17 0.0003
845 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
846 LOWER LIMB FRACTURE 5 0.0003
847 GLAUCOMA 5 0.0003
848 PNEUMONIA 84 0.0003
849 HAEMORRHAGE 27 0.0003
850 RASH MACULAR 9 0.0003
851 ATRIAL FIBRILLATION 25 0.0003
852 DRUG INEFFECTIVE 337 0.0003
853 PARAESTHESIA 40 0.0003
854 SEPTIC SHOCK 11 0.0003
855 ULCER 4 0.0003
856 CEREBRAL HAEMORRHAGE 9 0.0003
857 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
858 HYPONATRAEMIA 14 0.0002
859 FULL BLOOD COUNT DECREASED 5 0.0002
860 PRODUCT PHYSICAL ISSUE 5 0.0002
861 RESTLESSNESS 9 0.0002
862 PULMONARY OEDEMA 11 0.0002
863 INTENTIONAL DOSE OMISSION 7 0.0002
864 BLINDNESS 10 0.0002
865 HERPES ZOSTER 14 0.0002
866 LUNG NEOPLASM MALIGNANT 10 0.0002
867 EXPOSURE DURING PREGNANCY 15 0.0002
868 PULMONARY HYPERTENSION 5 0.0002
869 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
870 KNEE ARTHROPLASTY 5 0.0002
871 CHRONIC KIDNEY DISEASE 18 0.0002
872 CARDIOVASCULAR DISORDER 6 0.0002
873 HEMIPARESIS 4 0.0002
874 HEPATITIS 6 0.0002
875 BLISTER 13 0.0002
876 VAGINAL HAEMORRHAGE 10 0.0002
877 DRUG DOSE OMISSION 38 0.0002
878 DISORIENTATION 9 0.0002
879 LYMPHOCYTE COUNT DECREASED 4 0.0002
880 ACNE 17 0.0002
881 FEAR 6 0.0002
882 THROAT IRRITATION 10 0.0002
883 END STAGE RENAL DISEASE 4 0.0002
884 METABOLIC ACIDOSIS 7 0.0002
885 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
886 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
887 COGNITIVE DISORDER 10 0.0002
888 PRODUCT QUALITY ISSUE 29 0.0002
889 EYE PAIN 12 0.0002
890 PHOTOPHOBIA 4 0.0002
891 STAPHYLOCOCCAL INFECTION 7 0.0002
892 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
893 COLITIS 8 0.0002
894 PROTEINURIA 4 0.0002
895 ACUTE RESPIRATORY FAILURE 4 0.0002
896 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
897 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
898 DRUG INTOLERANCE 20 0.0002
899 CARDIAC ARREST 17 0.0002
900 ENCEPHALOPATHY 5 0.0002
901 ACUTE MYOCARDIAL INFARCTION 6 0.0002
902 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
903 OSTEONECROSIS OF JAW 5 0.0002
904 DELIRIUM 7 0.0002
905 PULMONARY EMBOLISM 19 0.0002
906 SEIZURE 23 0.0002
907 GASTRIC CANCER 5 0.0002
908 PANCYTOPENIA 11 0.0002
909 SKIN IRRITATION 9 0.0002
910 ACUTE KIDNEY INJURY 30 0.0002
911 RENAL FAILURE 26 0.0002
912 THERAPY CESSATION 10 0.0002
913 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
914 UNDERDOSE 14 0.0002
915 ROAD TRAFFIC ACCIDENT 8 0.0002
916 DYSGEUSIA 14 0.0002
917 SUICIDAL IDEATION 17 0.0002
918 DEVICE MALFUNCTION 13 0.0002
919 PRODUCT DISPENSING ERROR 4 0.0002
920 MYOCARDIAL INFARCTION 32 0.0002
921 SKIN LESION 5 0.0002
922 LIP SWELLING 6 0.0002
923 FUNGAL INFECTION 6 0.0002
924 HEPATOTOXICITY 4 0.0002
925 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
926 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
927 CHROMATURIA 4 0.0002
928 RASH 77 0.0002
929 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
930 MUSCLE TWITCHING 4 0.0002
931 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
932 INCORRECT DOSE ADMINISTERED 39 0.0002
933 DEEP VEIN THROMBOSIS 11 0.0002
934 ASTHMA 19 0.0002
935 PRODUCT PRESCRIBING ERROR 4 0.0002
936 INTERSTITIAL LUNG DISEASE 8 0.0002
937 EMOTIONAL DISTRESS 20 0.0002
938 MENTAL IMPAIRMENT 4 0.0002
939 TOXICITY TO VARIOUS AGENTS 27 0.0002
940 PRODUCT USE ISSUE 30 0.0002
941 DYSARTHRIA 6 0.0002
942 CEREBROVASCULAR ACCIDENT 27 0.0002
943 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
944 URTICARIA 26 0.0002
945 RESPIRATORY TRACT INFECTION 4 0.0002
946 EYE DISORDER 5 0.0002
947 THERAPEUTIC RESPONSE DECREASED 9 0.0001
948 THROAT TIGHTNESS 4 0.0001
949 RENAL CANCER 7 0.0001
950 HYPERSENSITIVITY 27 0.0001
951 ABNORMAL DREAMS 4 0.0001
952 ANAPHYLACTIC REACTION 8 0.0001
953 LEUKOPENIA 7 0.0001
954 NEUTROPENIA 19 0.0001
955 EYE IRRITATION 8 0.0001
956 PRODUCT SUBSTITUTION ISSUE 8 0.0001
957 DEVICE LEAKAGE 6 0.0001
958 PANIC ATTACK 5 0.0001
959 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
960 HEPATIC FUNCTION ABNORMAL 5 0.0001
961 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
962 ECZEMA 7 0.0001
963 THERAPY NON-RESPONDER 6 0.0001
964 EPILEPSY 4 0.0001
965 SKIN EXFOLIATION 11 0.0001
966 FEMUR FRACTURE 4 0.0001
967 COMA 6 0.0001
968 RASH ERYTHEMATOUS 6 0.0001
969 MOVEMENT DISORDER 4 0.0001
970 CARDIAC FAILURE CONGESTIVE 10 0.0001
971 PROSTATE CANCER 10 0.0001
972 WITHDRAWAL SYNDROME 5 0.0001
973 BREAST CANCER 11 0.0001
974 SPEECH DISORDER 6 0.0001
975 RHEUMATOID ARTHRITIS 13 0.0001
976 MYELOSUPPRESSION 4 0.0001
977 C-REACTIVE PROTEIN INCREASED 4 0.0001
978 HALLUCINATION 8 0.0001
979 DRY EYE 5 0.0001
980 ABORTION SPONTANEOUS 4 0.0001
981 CARDIO-RESPIRATORY ARREST 4 0.0001
982 AGITATION 7 0.0001
983 COLITIS ULCERATIVE 4 0.0001
984 LUNG DISORDER 4 0.0001
985 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
986 DRUG INTERACTION 12 0.0001
987 CONVULSION 4 0.0001
988 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
989 INJURY 4 0.0001
990 SKIN BURNING SENSATION 4 0.0001
991 DRUG DEPENDENCE 6 0.0000
992 OVERDOSE 7 0.0000